Along with displaying epileptiform activity, decreased levels of Nav1.1 expression have been observed across multiple transgenic AD mouse models [68,69,70] as well as AD patients [70], further supporting the pathophysiological role of this channel in AD. This evidence concerns the gene SCN1A and Alzheimer disease.